Rapport Therapeutics, Inc. (RAPP) expects to raise $136 million in an IPO on Friday, June 7th, IPO Scoop reports. The company will be issuing 8,000,000 shares at a price of $16.00-$18.00 per share. Rapport Therapeutics, Inc. has a market-cap of $601.4 million. Goldman Sachs, Jefferies, TD Cowen and Stifel served as the underwriters for the […]

Related Keywords

San Francisco , California , United States , Delaware , Boston , Massachusetts , David Bredt , Eli Lilly , Goldman Sachs , News Ratings For Rapport Therapeutics Inc , Rapport Therapeutics Inc , University Of California , Rapport Therapeutics , Third Rock Ventures , Chief Scientific Officer , Global Head , Neuroscience Discovery , Janssen Pharmaceutica , Vice President , Janssen License ,